Expenditure and financial burden for common cancers in China: a hospital-based multicentre cross-sectional study

Abstract

Background Comprehensive health economic evaluation, a key component of the Cancer Screening Program in Urban China (CanSPUC), was expected to support government policy-making on screening initiatives for common cancers (lung, breast, colorectal, oesophageal, liver, and stomach cancer) in urban China. Estimation of expenditure for cancer diagnosis and treatment from a societal perspective was an essential component. The aim of this study was to estimate direct medical and non-medical expenditure and to discern the resultant fi nancial burden. Methods A multicentre cross-sectional survey of patients with target cancers or precancerous lesions was conducted in 37 tertiary hospitals in 13 provinces across China, from 2012 to 2014. Each patient was interviewed with a structured questionnaire for sociodemographic, clinical, and expenditure information. Expenditure data was converted to 2014 values and presented as US$. Expenditure and fi nancial burden were quantifi ed as a whole and by subgroups.

Chinese version of the Cancer Support Person’s Unmet Needs Survey-Sort Form: A psychometric study

“…Despite some recommendations TA B L E 6 Discriminant validity of the SPUNS-SFC: comparisons between known-subgroups using independent-sample t test (n = 1,026) that a factor should include a minimum of three items (Costello & Osbome, 2005), we decided that the finance domain of the SPUNS-SFC which only included two items would be maintained, as these two items were considered to be highly relevant to cancer caregivers in China. For instance, in mainland China, although medical insurance coverage is substantial, cancer patients and their families still bear enormous out-of-pocket costs (Huang et al, 2016;Zhao et al, 2016). Therefore, assessing Chinese cancer caregivers' unmet financial needs in a separate dimension is necessary and meaningful.…”

A symptom‐based model to predict colorectal cancer in low‐resource countries: Results from a prospective study of patients at high risk for colorectal cancer

“…Survival is strongly related to the stage at diagnosis: 5‐year survival is greater than 90% for patients with stage I CRC but is only 10% for patients with stage IV CRC . In addition, the cost of treatment rises significantly as the stage of the disease increases . Two strategies are commonly used to detect early‐stage CRC: population‐based CRC screening and early‐diagnosis strategies in symptomatic patients .…”

“…[5][6][7] In addition, the cost of treatment rises significantly as the stage of the disease increases. 8 Two strategies are commonly used to detect early-stage CRC: population-based CRC screening and early-diagnosis strategies in symptomatic patients. 9,10 Screening for CRC leads to a reduction in emergency presentations, a reduction in the proportion of cancers with adenomatous polyps (adenomas), and a shift to a diagnosis at earlier stages.…”

Bibliometric analysis on randomized controlled trials of colorectal cancer over the last decade

“…With the level of diagnosis and treatment increasingly improving, the early diagnosis rate of colorectal cancer has been significantly improved. The innovation and development of minimally invasive technology and the reform of concept of diagnosis and treatment make local recurrence rate after surgery reducing to 5% [13] , The medical workers in the field of colorectal cancer in China have achieved remarkable results during the past 10 years. However, due to a large population base in China, there are still nearly 400,000 new patients and nearly 200,000 deaths every year [14] .…”